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Background:  Distal  embolization  during  percutaneous  coronary  intervention  (PCI)  may deteriorate
microvascular  reperfusion  in patients  with  ST-elevation  myocardial  infarction  (STEMI).  Reperfusion  at
the  coronary  microvascular  level  is  important  for STEMI  and  culprit  plaque  is associated  with  distal
embolization  and  microvascular  reperfusion.  ST-segment  resolution  (ST-R)  in the  electrocardiogram
reﬂects  microvascular  reperfusion  after  primary  PCI. Longitudinal  extent  of lipid  pool  assessed  by  optical
coherence  tomography  (OCT)  may  predict  the  risk  of failure  of  microvascular  reperfusion  after  primary
PCI.
Methods  and results:  This  study  consisted  of 39  patients  with  STEMI  who  underwent  primary  PCI  within
24  h after  the  onset  of  chest  pain.  Immediately  after  thrombectomy,  OCT  was performed  and  length  of
lipid  pool  was  measured.  Microvascular  reperfusion  after  primary  PCI  was  assessed  by ST-R,  which  was
deﬁned  as >50%  decrease  in ST elevation  at 1 h after primary  PCI.
There were  23  patients  with  ST-R  and 16  patients  without  ST-R,  with  no signiﬁcant  difference  in  baseline
clinical  and  angiographical  variables  between  the  2  groups.  Final  thrombolysis  in  myocardial  infarction
3  ﬂow  was  obtained  in all of  the  patients.  Peak  creatine  kinase  was  signiﬁcantly  higher  in the  ST-R  (−)
group  than  in  the ST-R  (+)  group  (p =  0.01).  Length  of lipid pool  was  10.1  ±  2.8 mm  in  the  ST-R  (−)  group
and  7.8  ±  3.2  mm  in the  ST-R  (+)  group  (p =  0.02).  In receiver  operating  characteristics  curve  assessing  the
ability  of length  of  lipid  pool  to  predict  ST-R,  area  under  the  curve  was  0.74  (p = 0.02).  Length  of  lipid  pool
>9.0  mm  best  predicted  the  absence  of  ST-R  with  sensitivity  88%  and  speciﬁcity  78%.
Conclusions:  These  ﬁndings  suggest  that  length  of  lipid  pool  estimated  by  OCT  may  predict  microvascular
no-reﬂow  after  primary  PCI.
3  Jap©  201
ntroductionPrimary percutaneous coronary intervention (PCI) is a well-
stablished reperfusion strategy for ST-segment elevation myocar-
ial infarction (STEMI) patients [1]. However, distal embolization
uring PCI may  deteriorate microvascular reperfusion for STEMI
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patients and may  cause no-reﬂow phenomenon [2–5]. Despite
early restoration of Thrombolysis in Myocardial Infarction (TIMI)
grade 3 ﬂow in the infarct related artery (IRA), microvascular
reperfusion may  fail to be acquired in a substantial portion of the
jeopardized myocardium [2–7] and no-reﬂow phenomenon is asso-
ciated with worse long-term outcome after STEMI [8]. ST-segment
resolution (ST-R) on the electrocardiogram (ECG) reﬂects myocar-
dial ﬂow and microvascular reperfusion after primary PCI rather
than epicardial ﬂow and predicts better myocardial salvage and
clinical outcome [9,10]. Numerous efforts have been made to detect
high-risk plaque which may cause no-reﬂow after primary PCI,
using several imaging devices. Of these, intravascular ultrasound
vier Ltd. All rights reserved.
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IVUS) was most frequently used for this purpose. Several reports
ave suggested that culprit lesion assessment by IVUS could pre-
ict distal embolization and a large infarct size during PCI and
arge lipid-rich plaque at culprit lesions may  be associated with
o-reﬂow phenomenon [11–13]. Although IVUS can assess plaque
olume and, using several signal processing methods, may  obtain
issue character information, resolution of IVUS is relatively low.
ptical coherence tomography (OCT) has been recently developed
s a high-resolution imaging method to observe culprit lesions
ore clearly. It also provides clear images of lipid pool which may
ave great risk of no-reﬂow if PCI is performed. There are few
ata on the prognostic utility of OCT in patients with STEMI who
nderwent primary PCI. This study was undertaken to assess the
ssociation between longitudinal extent of lipid pool assessed by
CT and microvascular reperfusion estimated by ST-R.
ethods
tudy  patients
We  enrolled 39 patients with STEMI who underwent primary
CI and performed OCT within 24 h after symptom onset from May
008 to February 2010 at Hiroshima City Hospital. We  excluded
atients with culprit lesions in the left main trunk, ostium lesions,
xtremely tight lesions or tortuous vessels where we  expected
ifﬁculty in advancing the OCT catheter, and target vessel refer-
nce diameter of 4 mm expected limitation in OCT evaluation.
ll patients were treated by aspiration thrombectomy and stent
eployment without any distal protection device. Further, we
xcluded patients with angiographic no-reﬂow to focus on the
icrovascular no-reﬂow phenomenon. STEMI was  diagnosed by
hest pain consistent with ongoing myocardial ischemia persist-
ng longer than 30 min  with ST-segment elevation of >0.1 mV  in 2
imb leads or >0.2 mV in 2 contiguous precordial leads, and a rise
n serum creatine kinase (CK) levels to more than twice the upper
imit of normal. CK was measured every 3 h. Emergency coronary
ngiography and primary PCI were performed in a manner as previ-
usly reported [14]. Selective coronary angiography was  performed
n multiple projections before the initiation of reperfusion ther-
py. Immediately after diagnostic angiography, primary PCI was
erformed. OCT was performed after getting TIMI ﬂow grade 3
y aspiration thrombectomy. Informed consent was obtained from
ach patient. This study was approved by the ethical committee at
iroshima City Hospital.
ig. 1. Lipid pool and ﬁbrous cap thickness in optical coherence tomography (OCT). Lipid 
quare  of broken white lines in A was expanded to B. Fibrous cap thickness was  deﬁned
ool  (B, red arrow). (For interpretation of references to color, in this ﬁgure legend, the readiology 62 (2013) 71–76
OCT procedures
The  OCT system was  the LightLab M2 TD-OCT Imaging Sys-
tem (LightLab, Westford, MA,  USA). A 0.016-in. OCT catheter was
advanced to the distal end of the culprit lesion, and to remove
the blood from the view, the 3-Fr occlusion balloon was  inﬂated
to 0.5 atm at proximal site of the lesion and lactate Ringer’s solu-
tion was  infused into the coronary artery from the distal tip of the
occlusion balloon catheter at 0.5 ml/s. The entire length of the cul-
prit lesion was imaged with an automatic pullback device moving
at 1 mm/s, and the OCT image clearly visualized the culprit lesion
[15,16].
OCT image analysis
All  images were stored digitally for subsequent analysis. Anal-
ysis of the OCT images was  performed by 2 reviewers blinded
to the results of the ECG analyses. OCT images were analyzed
using validated criteria for thrombus characterization, plaque
characterization, and ﬁbrous cap thickness was determined as
reported previously [15–23]. Red thrombi were deﬁned as high-
backscattering protrusions inside the lumen of artery, with
signal-free shadow, white thrombi were deﬁned as signal-rich,
low-backscattering protrusions, and mixed thrombi were deﬁned
as mixture with both characteristics. Thrombus was semiquanti-
ﬁed as the number of involved quadrants on the cross-sectional
OCT image. Lipid pool was characterized by a signal-poor region in
OCT image (Fig. 1A, white arrows). Lipid was  semiquantiﬁed as the
number of involved quadrants on the cross-sectional OCT image.
Lipid-rich plaque was  deﬁned as plaque with 2 quadrants. Brieﬂy,
ﬁbrous cap thickness was deﬁned as the minimum distance from
the coronary artery lumen to inner border of lipid pool (Fig. 1B,
red arrow). Cap thickness for each image was  measured 3 differ-
ent times, and the average value was computed. When lipid was
present in 2 quadrants in any of the images within a plaque, it
was considered a lipid-rich plaque. For each patient, the cross-
sectional image with the thinnest ﬁbrous cap was  used for analysis.
The thin cap ﬁbroatheroma (TCFA) was deﬁned as a plaque with
lipid content in 2 quadrants and the thinnest part of the ﬁbrous
cap measuring <65 m.  Culprit plaque was  deﬁned as the ruptured
plaque or the plaque with the thinnest ﬁbrous cap or thrombus.
The length of lipid pool was  measured as consecutive longitudi-
nal length of lipid pool at culprit plaque assessed by OCT (Fig. 2).
Cross-sectional views correspond to the sections indicated by A,
B, C, and D on the longitudinal views. Thrombus was  observed in
pool was characterized by a signal-poor region in OCT image (A, white arrows). The
 as the minimum distance from the coronary artery lumen to inner border of lipid
der is referred to the web version of this article.)
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F (OCT). Cross-sectional views correspond to the sections indicated by the A, B, C, and D on
t ved in C. This plaque was  deﬁned as culprit plaque. The edges of this plaque were A and
D ipid pool at culprit plaque assessed by OCT.
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Table 1
Clinical characteristics.
ST-R (+)
(n  = 23)
ST-R  (−)
(n=16)
p-Value
Age (yr) 63 ± 12 65  ± 7 0.54
Male  20 (86%) 13 (81%) 0.62
Hypertension 10 (43%) 5 (31%) 0.44
Diabetes mellitus 7 (30%) 5 (31%) 0.95
Dyslipidemia 11 (47%) 6 (37%) 0.52
Current smoker 13 (56%) 11 (68%) 0.43
Time to angiography (h) 3.3 ± 3.9 5.5 ± 5.4 0.14
Killip class 3–4 0 (0%) 0 (0%) –
Medications on admission
Statins  2 (8%) 3 (18%) 0.35
ACE-I/ARB 4 (17%) 0 (0%) 0.07
blocker 0 (0%) 0 (0%) –
ST-R, ST-segment resolution; ACE-I/ARB, angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers.
Table 2
Angiographical characteristics.
ST-R (+)
(n  = 23)
ST-R (−)
(n  = 16)
p-Value
Culprit vessel 0.16
LAD 8 (34%) 9 (56%)
LCX 1 (4%) 2 (12%)
RCA 14 (60%) 5 (31%)
Initial TIMI ﬂow grade 0–1 15 (65%) 14 (87%) 0.10
Final TIMI ﬂow grade 3 23 (100%) 16 (100%) –
Multivessel disease 10 (43%) 4 (25%) 0.23
Collateral ﬂow 5 (21%) 5 (31%) 0.50
Reference vessel diameter, mm 3.25 ± 0.37 3.23 ± 0.28 0.86
Minimal lumen diameter, mm 0.62 ± 0.22 0.62 ± 0.23 0.98
ST-R, ST-segment resolution; LAD, left anterior descending coronary artery; LCX,ig. 2. Longitudinal extent of lipid pool assessed by optical coherence tomography 
he  longitudinal views. Thrombus was observed in B and plaque rupture was  obser
.  The length of lipid pool was measured as the consecutive longitudinal length of l
 and plaque rupture was observed in C. This plaque was deﬁned
s culprit plaque. If detection of consecutive lipid pool was  difﬁ-
ult due to a lot of red thrombus, consecutiveness of culprit plaque
as evaluated using many distal or proximal sagittal frames and
andmarks such as side branches.
CG analysis
A  12-lead ECG was recorded on admission and 1 h after the
nal angiogram, at a paper speed of 25 mm/s  and an ampliﬁcation
f 10 mm/mV.  ST-R was deﬁned as >50% decrease of ST segment
levation at 1 h after primary PCI at the lead in which ST seg-
ent elevation was greatest on the initial electrocardiogram [9,24].
atients were stratiﬁed into two groups based on ST-R; ST-R (+)
roup (n = 23) was compared with ST-R (−) group (n = 16).
tatistical analysis
We  used standard statistical methods. We  tested the signiﬁ-
ance of difference with 2 test for categorical variables. Student’s
 test was used for continuous variables. We  used the JMP  statis-
ical package (version 5.0.1J; SAS, Cary, NC, USA) for all statistical
ests. A signiﬁcance level of 0.05 was used and two-tailed tests were
pplied.
esults
ST-R (−) was observed in 16 of 39 patients (41.0%). Clinical
haracteristics of the study patients are shown in Table 1. There
as no signiﬁcant difference in these clinical variables between
he ST-R (+) and ST-R (−) groups. There was a tendency toward
onger time from onset to angiography in the ST-R (−) group, but
he difference did not reach statistical signiﬁcance. No signiﬁcant
ifferences in implanted stent length, implanted stent diameter,
nd balloon inﬂation pressure were observed between the ST-R
+) and ST-R (−) groups (implanted stent length: 18.8 ± 5.6 mm vs.
9.7 ± 5.6 mm,  p = 0.61; implanted stent diameter: 3.22 ± 0.36 mm
s. 3.10 ± 0.35 mm,  p = 0.32; inﬂation pressure: 13.5 ± 2.2 atm vs.
3.8 ± 2.6 atm, p = 0.68). Angiographical characteristics of the study
atients are shown in Table 2. There was no signiﬁcant difference
n infarct location, initial TIMI ﬂow grade 0–1, multivessel dis-
ase, collateral ﬂow, reference vessel diameter, and minimal lumen
iameter between the ST-R (+) group and the ST-R (−) group. All
atients achieved ﬁnal TIMI 3 ﬂow grade. Although 6 patients had
IMI 2 ﬂow grade after stent deployment, they achieved ﬁnal TIMIleft circumﬂex coronary artery; RCA, right coronary artery; TIMI, thrombolysis in
myocardial infarction.
3 ﬂow grade after intracoronary administration of nicorandil. Peak
CK was  signiﬁcantly higher in the ST-R (−) group than in the ST-R
(+) group (4249 ± 2377 IU/l vs. 2479 ± 1750 IU/l, p = 0.01, Fig. 3). OCT
ﬁndings of the study patients are shown in Table 3. Thrombi were
observed in all patients. After aspiration thrombectomy, residual
thrombus tended to be more frequently found by OCT in the ST-R
(−) group than the ST-R (+) group (p = 0.07). Residual red thrombus
was found in 9 patients in the ST-R (+) group and in 5 patients in
the ST-R (−) group (p = 0.61). Residual white thrombus was  found
in 12 patients in the ST-R (+) group and in 10 patients in the ST-R
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Fig. 3. Peak creatine kinase (CK) in patients without ST-segment resolution (ST-R)
(−) and those with ST-R (+). Peak CK was signiﬁcantly higher in the ST-R (−) group
than  in the ST-R (+) group (4249 ± 2377 IU/l vs. 2479 ± 1750 IU/l).
Table 3
Optical coherence tomography ﬁndings.
ST-R (+)
(n  = 23)
ST-R (−)
(n  = 16)
p-Value
Culprit plaque
Thrombus
Red/white/mixed 9/12/2 5/10/1 0.61/0.52/0.77
No. of quadrants, 1/2/3/4 5/8/7/3 0/5/6/5 0.07
Plaque rupture 15 (65%) 8 (50%) 0.34
Fibrous cap thickness, m 79±74 54±30 0.20
Lipid plaque, no. of quadrants
1/2/3/4  2/2/16/3 1/2/11/2 0.97
Lipid-rich plaque 21 (91%) 15 (93%) 0.75
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Fig. 5. Receiver operating characteristics to determine the optimal cut-off value
for the length of lipid pool to predict ST-segment resolution (ST-R) (−). The areaTCFA 14 (60%) 12 (75%) 0.35
Length of lipid pool, mm 7.8±3.2 10.1±2.8 0.02
T-R, ST-segment resolution; TCFA, thin cap ﬁbroatheroma.
−) group (p = 0.52). There was no signiﬁcant difference in throm-
us characterization, plaque rupture, ﬁbrous cap thickness, and the
ncidence of TCFA between the ST-R (+) and ST-R (−) groups. How-
ver, length of lipid pool was signiﬁcantly higher in the ST-R (−)
roup than in the ST-R (+) group (Fig. 4). Receiver operating char-
cteristics (ROC) curve assessing ability of length of lipid pool to
redict ST-R after primary PCI is shown in Fig. 5. The area under
he curve was 0.74 (p = 0.02). Length of lipid pool > 9.0 mm best
redicted the absence of ST-R, with a sensitivity of 88% and speci-
city of 78%. Peak CK was signiﬁcantly higher in patients with
ength of lipid pool > 9.0 mm than those without (3968 ± 2504 IU/l
s. 2481 ± 1578 IU/l, p = 0.03).
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ig. 4. Relation between length of lipid pool estimated by optical coherence
omography  (OCT) and ST-segment resolution (ST-R). Length of lipid pool was  sig-
iﬁcantly higher in the ST-R (−) group than in the ST-R (+) group.under  the curve was  0.74 (p = 0.02). Length of lipid pool > 9.0 mm best predicted the
absence of ST-R, with a sensitivity of 88% and speciﬁcity of 78%.
Discussion
The major ﬁnding of the present OCT study was that length of
lipid pool estimated by OCT may  predict ST-R after primary PCI. In
addition, there was  no signiﬁcant difference between number of
lipid plaques, ﬁbrous cap thickness, and TCFA assessed by cross-
sectional OCT images and ST-R.
Previous studies have shown that abnormalities at the level of
the microvasculature cause no-reﬂow phenomenon during reper-
fusion after prolonged coronary artery occlusion [25,26]. The
pathogenetic cause of no-reﬂow phenomenon is multifactorial.
The capillary structure becomes disorganized in the no-reﬂow
zone because of endothelial dysfunction, compression by tissue,
myocyte edema, neutrophil inﬁltration, the generation of oxygen
free radicals, and distal embolism [27–29]. In humans, no-reﬂow
is caused by the variable combination of 4 pathogenetic com-
ponents: (1) distal atherothrombotic embolization; (2) ischemic
injury; (3) reperfusion injury; and (4) susceptibility of coronary
microcirculation to injury [30]. In addition to ischemic injury and
reperfusion injury in patients with STEMI undergoing primary
PCI, distal embolization of disrupted plaque contents and resid-
ual thrombus may  lead to progressive decline of coronary ﬂow
and further deteriorate no reﬂow [31]. Thus, it has clinical impor-
tance to estimate the lesion probability of distal embolization for
the prediction of no-reﬂow phenomenon.
Several methods, including coronary angiography (myocardial
blush grade), myocardial contrast echocardiography, and mag-
netic resonance imaging have been used to assess microvascular
reperfusion. Electrocardiographic assessment of ST-R is one of the
established measures for microvascular reperfusion. Numerous
studies have shown a remarkably consistent relationship between
ST-R and subsequent mortality [10,32,33]. Notably, it was  reported
that approximately one-third of patients with TIMI ﬂow grade 3
and myocardial blush grade (MBG) 2–3 do not exhibit ST-R [34]. In
the current study, where ﬁnal TIMI 3 ﬂow grade was achieved in
all study patients, ST-R (−) was observed in 41% patients and peak
CK was signiﬁcantly higher in ST-R (−) than in ST-R (+). Although
all patients achieved ﬁnal TIMI 3 ﬂow grade in our study, angiog-
raphic no-reﬂow was reported to occur in 5–6% of STEMI patients
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35,36]. Intracoronary administration of nicorandil and the exclu-
ion of patients with large vessel diameter may  have led to all
atients achieving ﬁnal TIMI3 ﬂow grade.
Previous studies have reported that a high atherothrombotic
urden and a decrease in plaque volume as assessed by IVUS dur-
ng PCI were associated with microvascular reperfusion after PCI in
atients with STEMI [37]. In the current study, we  evaluated num-
er of lipid pool, ﬁbrous cap thickness, and TCFA as a cross-sectional
CT image at culprit lesions. However, we could not ﬁnd any sig-
iﬁcant correlations between cross-sectional OCT images and ST-R.
hese ﬁndings suggested that it may  be insufﬁcient to evaluate only
ne cross-sectional OCT image to quantify accurate plaque burden.
o evaluate longitudinal extent of lipid at multi cross-sectional OCT
mages may  be needed to quantify the whole plaque burden accu-
ately. With high image resolution, OCT can evaluate lipid pool
learly, because OCT could identify edge of lipid to minimize the
ffect of artifacts such as thrombus and calciﬁcation.
To prevent no-reﬂow phenomenon during PCI, several trials
ave been conducted with a variety of embolic distal protection
evices. However, conﬂicting results have cast doubt on whether
he routine use of embolic protection devices is warranted [30,38].
he Drug Elution and Distal Protection in ST Elevation Myocar-
ial Infarction (DEDICATION) trial suggested that in primary PCI for
TEMI, the routine use of distal protection increased the incidence
f stent thrombosis and clinically driven target lesion/vessel revas-
ularization [39]. Therefore, it is necessary to determine patients
ho will suffer from embolic obstruction and no-reﬂow after PCI
ithout distal protection devices. Prospective studies will be advo-
ated to investigate the propriety of OCT-guided use of distal
rotection devices to prevent no-reﬂow during primary PCI for AMI.
tudy limitations
The  major limitation of this study is small sample size. Because
f the invasive nature of this study, only 39 patients were included.
icrovascular no-reﬂow was assessed by electrocardiographic ST-
. Use of other measures, including MBG  by coronary angiography,
icrovascular obstruction by magnetic resonance imaging, and
ontrast deﬁcit by contrast echocardiography, might have provided
dditional information on microvascular reperfusion. OCT was  used
s the only intravascular imaging modality. Comparison of ﬁnd-
ngs of OCT to those of IVUS or angioscopy was  not performed.
spiration thrombectomy was performed routinely before the OCT
xamination. This procedure may  affect the plaque and thrombus
orphology. This study has patient selection bias. The patients with
ngiographic no-reﬂow were excluded. Because of the nature of
CT, this study had no other choice than to exclude patients with
arge vessel, severe stenosis, and tortuous coronary lesions. Inabil-
ty to measure plaque volume is one of the major limitations of OCT.
his may  have affected the results.
onclusions
The presence of longer culprit lipid pool as estimated by OCT
as associated with a higher incidence of ST-R (−). These ﬁnd-
ngs suggest that longitudinal evaluation of lipid pool by OCT may
redict microvascular no-reﬂow after primary PCI. Further studies
hould be advocated to investigate the better therapeutic options
or high-risk patients to reduce microvascular no-reﬂow.unding
There is no ﬁnancial support for this study.
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